Skip to main content

Table 3 Answers to question 6 of the survey: radiopharmaceuticals in clinical use in European countries.

From: Multimodality imaging in Europe: a survey by the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM)

 

ESR

EANM

18F-Fluoro-2-deoxy-D-glucose (FDG)

73%

99%

18F-Dopa

10%

29%

18F-Fluorocholine

10%

23%

18F-Fluoroethyl-L-tyrosine (FET)

5%

12%

18F-Fluorothymidine (FLT)

4%

14%

Other 18F

4%

12%

Any 11C

2%

14%

Rubidium-82

1%

6%

15O-Water

1%

11%

Others

7%

13%